bluebird bio (BLUE) PT Lowered to $14 at RBC Capital
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 13
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 13
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on bluebird bio (NASDAQ: BLUE) to $14.00 (from $26.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- BE Semiconductor (BESI:NA) (BESIY) PT Raised to EUR400 at Needham
- Svenska Handelsbanken AB (SHBA:SS) (SVNLY) PT Raised to SEK136 at Kepler Cheuvreux
- Morgan Stanley Assumes Moncler SpA (MONC:IM) (MONRY) at Equalweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
